Abstract
Introduction
The incidence of chylothorax after congenital cardiac surgery has been reported between 2-6.6% [1] [2] [3] and is associated with substantial morbidity, mortality and a significantly longer length of hospital stay [1] . Conservative management involves chest tube drainage, dietary restrictions (medium chain triglyceride, parenteral nutrition) and use of octreotide in a staged protocol [2, 3] .
Presence of milky or creamy coloured pleural effusion is considered affirmative of chylothorax. Microscopic and biochemical analyses of the pleural effusion should show triglycerides> 1.2 mmol/L and cell count > 1000 cell/μL with a predominance of lymphocytes [4, 5] .
The refractory cases do require surgical interventions in the form of pleurodesis, thoracic duct embolization and/or thoracic duct ligation, post pleurodesis day and did not recur again. He is currently also been followed by endocrinologist for the thyroid function and is on replacement therapy with L-thyroxine.
Case 2
6 months old male patient underwent repair of Atrioventricular septal defect (AVSD) with Pulmonary Artery debanding. In the immediate postoperative period, patient developed bilateral chylothorax with average fluid output of 114ml/day. After failed initial conservative treatment, bilateral pleurodesis was performed and drainage decreased to 37ml / day for next 4 days and thereafter stopped on 6 th day. Thyroid function was normal. Hospital course was complicated by sternal wound infection and feeding difficulties which were managed by secondary wound closure and percutaneous endoscopic gastrostomy respectively. Average drainage was 245ml/day which decreased to average 57ml/day after pleurodesis and completely stopped on day 14. Subsequent follow up revealed normal thyroid function and the patient is healthy. 
Discussion
Previously, chemical pleurodesis with talc, bleomycin, or tetracycline have been reported for chylothorax. 2 However, the intrapleural injection of povidone-iodine as a chemical agent for pleurodesis in surgical chylothorax has been sparingly reported. Povidone iodine has previously been used for the sclerosis of postoperative pelvic lymphoceles [6, 7] and pleural lavage of empyema in adults. (8) A 100% success rate has been reported when this agent was administered to 15 adult patients with a malignant pleural effusion [9] . In the pediatric age group, chylothorax following cardiac surgery for the congenital heart diseases is the most common cause [10] . Chylothorax can also occur after obstruction in the superior vena cava without anatomic injury of lymph channels. Blalock et al. proved experimentally that occlusion of the superior vena cava (SVC) can produce chylothorax [11, 12] . Therefore, certain cardiovascular procedures like the Fontan operation are more prone to this complication due to the expected increase in SVC pressure. Ongoing losses cause compromise in the nutritional status and hence adequate calorie intake, protein supplementation and electrolyte balance are important modes in the management. Babies are at risk of sepsis as a result of loss of prothrombin, immunoglobulins, fibrinogen and lymphocytes. This complication has been on the rise in pediatric cardiac surgery, as observed in several reports [13] .
Pleurodesis (PD) is one way to obtain pleural adhesion, thus obliterating chylous leaks. Brissaud O, et al reported that the chemical pleurodesis with povidine iodine was successful in three of the four neonates with congenital chylothorax [14] .
They used 5ml to 10ml of either 4% povidine iodine scrub or 10% povidone iodine dermique. The duration of chest tube occlusion varied from 3 hours to 5 hours. In our series, we used 10 ml of 4% povidine iodine through the pig tail catheters which was clamped for 3-5 hours during which the patient was monitored intensely. Mitanchez et al reported the use of 4 % povidone iodine for congenital chylothorax which was successful however the infant developed renal failure subsequently [15] . With the advent of aggressive initiation of non-operative management, the number of surgical procedures have decreased resulting in improving mortality rate from 50% before 1950's to 10-20% currently. We decided to administer intrapleural povidoneiodine when surgical abrasion of the pleura was being considered. This method requires general anaesthesia, with associated risks of adverse effects such as blood loss and pain. Previously, chemical pleurodesis with talc, bleomycin, or tetracycline has been performed in chylothorax [16] . The administration of either topical povidone iodine applications or the iodine-based contrast agents may lead to transient thyroid dysfunction, especially in infants [21] . Excess iodides may also induce thyrotoxicosis in susceptible individuals [22] . The mechanism of pleurodetic effect of povidine iodine is unknown. It may due to the low pH (2.97) of the sclerosing solution [23] . Iodine has strong oxidative and cytotoxic properties which induce a potent inflammatory response in the wall of any fluid-containing structure [4] . Povidoneiodine also has anti exudative properties related to the chelation of proteins [6] .
Olivares-Torres et al. reported two patients and neither of them presented signs or symptoms of hyperthyroidism, although they repeated povidine iodine pleurodesis second time to the patient in whom it was unsuccessful in the first instance [23] .
We found this method of pleurodesis to be quiet effective and recommend more extensive research on a larger subset of patients. Its early use may avoid more aggressive approaches such as thoracic duct embolization and surgical interventions.
